List of Biotech, Pharmaceutical & Life Sciences companies in Tennessee - 35

Founded in 1990, Aegis Sciences Corporation is a forensic toxicology and healthcare laboratory that provides science-driven drug testing and consulting services based in Nashville, TN. Aegis delivers evidence-based, clinically actionable information related to medication compliance, substance abuse, and drug-drug interactions through definitive testing of urine, oral fluid, or blood specimens. Aegis healthcare testing services are designed for the unique needs of healthcare specialties in the areas of Pain Management, Behavioral and Mental Health, Substance Use Disorder, Prenatal and Chronic Disease Management. Aegis provides clarity for enhanced patient care to a wide array of clinicians that serve Medicare, Managed Medicaid, Commercially Insured and Workers'​ compensation populations. In addition to healthcare testing services, Aegis offers anti-doping and forensic testing services to professional and amateur sports organizations, college and university athletic programs. Aegis’s biopharma lab provides molecular diagnostic services, including clinical trial services, pharmacogenetic testing, and other services.

We are a pediatric rare disease pharmaceutical development company. Asklepion Pharmaceuticals, LLC focuses on the discovery, development, and commercialization of pharmaceutical products for pediatric patients with few therapeutic options, due to the rarity of their conditions. Our pipeline currently focuses on rare and critical diseases in children.

BioPet Laboratories is a biotechnology company specializing in animal genomics. BioPet offers multiple product and services: PooPrints®, the DNA Solution for Dog Waste; BioPet Life Plan™, an interactive canine health and wellness management tool with Breed and Allergy Testing; DNA Proof of Parentage, canine parentage testing certification; Travel Dog™, an elite club for dogs and their owners; and the DNA World Pet Registry®, a state of the art database to store canine genetic information. As the parent company of the PooPrints® program BioPet works with more than 7,000 multifamily properties worldwide. With more than 800,000 individual canines in their database, BioPet is becoming an industry standard for canine genetics. BioPet was the first to offer a ground breaking price point reductions and one of the fastest processing times in the canine paternity industry. Historically excelling in canine DNA offerings such as breed analysis, parentage verification, and DNA matching of fecal samples, BioPet continues to expand its offerings in genetics and forensics. *BioPet Laboratories is accredited to the ISO/IEC 17025:2017 standard*

Crown, a privately held, fully integrated global skincare company, is committed to developing and providing a diverse portfolio of aesthetic, premium and therapeutic skincare products that improve the quality of life for its consumers throughout their skincare journey. An innovative company focused on skin science for life, Crown's unyielding pursuit of delivering therapeutic excellence and enhanced patient outcomes is why it has become a leader in Dermatology and Aesthetics. Crown has been listed on the Inc. 5000 Fastest Growing Privately Held Companies List for eight years and has expanded its distribution to over 38 countries. For more information, visit www.crownlaboratories.com.

Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops and commercializes FDA-approved branded prescription products. We are the largest publicly listed biopharmaceutical company founded and headquartered in Nashville, Tennessee. Nashville has become a leading center for health care in the United States, with over 300 companies headquartered here, and working in that industry. Cumberland is collaborating with Vanderbilt University and the Vanderbilt University Medical Center through a growing number of research and development programs. We are devoted to improving the quality of patient care and addressing poorly met medical needs. With a focus on underserved niche markets, we deliver products that serve patients in the U.S. market as well as internationally through select partnerships. Our commercial organization supports our branded products in the U.S., while our development team is working on new medicines for the future. Our primary focus is to improve patient care by providing differentiated products that offer clear advantages over other treatments. We also strive to deliver solutions that may help reduce costs for healthcare providers and, ultimately, patients.

DayTwo is leading the charge in personalized nutrition through cutting-edge microbiome analysis. Our mission is to empower individuals to take control of their health by understanding and optimizing their unique gut microbiome. About Us: We specialize in precision health through microbiome-based insights that drive personalized dietary recommendations. We decode the intricacies of the microbiome and translate it into practical solutions. Services: -Microbiome analysis for personalized nutrition optimization. -Predictive dietary recommendations based on individual microbiome composition. Why Choose Us: -Advanced technology: State-of-the-art sequencing methods (full shotgun) and proprietary algorithms -Supported by science: Microbiome insights combined with 25 years of diverse patient data, bolstered by research published in prestigious journals such as Nature, Cell, JAMA, and Diabetes Care -Largest collection of data: World's largest high-resolution sequenced data set of over 90,000 samples -Personalized approach: Recommendations based on each unique microbiome profile Join us on the journey to better health and unlock the potential of your microbiome with DayTwo. Connect with us to learn more!

EndoTheia was founded in 2018 to develop the next generation of flexible endoscopic devices, with the goal of increasing therapeutic yields through added flexibility and dexterity.

Molecular Pathology Laboratory Network (MPLN) has been at the forefront of laboratory medicine since its inception in 1989 and inspired the genesis of women's health testing using molecular diagnostics and technology. For decades, MPLN has continued to lead the way in specialty testing with an emphasis on women's health and oncology. MPLN strives to be the best client experience in laboratory medicine by bringing you comprehensive specialty testing, informatics using the latest digital applications, and unparalleled customer service. Our history is rich and rooted in our foundation of providing the very best in patient care, by exploring, developing, and delivering innovative solutions and technologies that elevate our field. Providing an expanding menu of molecular diagnostics, specialty anatomic pathology, flow cytometry, fluorescence in situ hybridization and cytogenetic testing, MPLN is dedicated to providing superior diagnostic services to our clients in pathology groups, hospitals, medical laboratories and physician groups nationwide. With a patient-focused approach, we honor an obligation to provide: · High-quality, timely results · Cost-effective testing strategies · Personalized consultative testing services from Board Certified Hematopathologists · Responsive and professional customer service

Imagine your drug’s effect lasting for months, after one single dose, and with fewer side effects—Hera Health Solutions is turning this vision into reality. Pharma companies can rapidly turn their promising APIs into long-acting, precise, and profitable therapeutics. How? Through our proprietary, cutting-edge nanotechnology-based drug delivery platform. The best part? The platform is: ♻️ Biodegradable: Resorbs into the body. 💊 Versatile: Delivers your API through implants, pellets, patches, and more. ⏳ Long-acting: Lasting up to 48 months! We are focused on significant healthcare and industry challenges. Our mission is to revolutionize drug delivery and transform patient care. 💭 Send the direct message “Long-acting” to Hera’s LinkedIn inbox to explore your API’s potential. Or visit: https://www.herahealthsolutions.com/contact

IDBiologics is a biotech startup that is focused on developing monoclonal antibodies against infectious disease targets with high unmet medical need. The company is located in Nashville, TN and also has an office in San Mateo, CA.

Insight Genetics provides advanced diagnostic solutions that enable personalized cancer care and improve patient outcomes. We have a portfolio of assays that detect specific cancer biomarkers and an innovative platform technology for assay development. Our products and services have application in translational research, clinical diagnostics and drug discovery.

Integrity Laboratories is a leading healthcare technology organization with a passion for precision medicine through molecular diagnostics. Our singular purpose is to enable clinicians, through advanced technologies, to improve patient outcomes while lowering total costs of healthcare delivery. We partner with the most trusted providers, healthcare systems, and payer networks to improve healthcare for all through high complexity, rapid clinical diagnostics.

Kythera Labs provides a data management and analytics platform to process healthcare data of all types and apply machine learning to look for signals that can report and predict behavioral patterns of patients, practitioners, health systems, and payers. We help healthcare information companies build enterprise-scale products to serve their customers, and we help all types of healthcare organizations (e.g. hospitals, pharmaceutical manufacturers, technology companies, government entities) understand the performance of their markets and the individual entities within them.

Lifetime Sciences (formerly MyGenetx) is a CLIA-certified and CAP accredited lab focused on molecular and advanced diagnostic testing. Lifetime Sciences is the primary resource for transitioning and implementing precision guided medicine. Our medical team consists of experts in research and clinical product development for genetics. MyPGt™ A pharmacogenetic panel to determine how you metabolize your medication(s). Traditional "one size fits all"​ dosing strategies can cause adverse drug reactions or drug inefficacy. MyHap2™ A proprietary genetic test to determine heart attack risk in patients with diabetes.

Nashville Biosciences is leveragingresources and proprietary analytical methods to help improve the prevention, diagnosis and treatment of a wide range of diseases.

NellOne Therapeutics is passionate about its work to pioneer advances in the field of tissue regeneration, developed over the course of many years of scientific research and exploration. Our highly experienced team is committed to improving outcomes for millions of patients across the world, and creating a successful business that truly makes a difference.

Robert “Tex” Walker is a veterinary vaccines manufacturer that adheres to USDA guidelines.

At Orio Therapeutics, our mission is to save lives by making the regenerative medicine dream accessible and a wide-spread reality. We are dedicated to developing novel regenerative drugs with increased efficacy and reduced side-effects, using cutting-edge targeted drug-delivery technologies to create novel therapeutic proteins. Notably, we strive to demonstrate that efficient drug delivery technologies are not confined to the development of complex devices and drug carriers but can be achieved based on clever molecular designs. We aim to initially validate our program pipeline through the development of a therapeutic molecule for myocardial infarction that has the potential to change the lives of patients following myocardial infarction by enabling faster recovery time and improved heart function.

OurCEL Solutions is Blood Assurance's cell therapy and research division.

Founded in 1965, PathGroup is a premier provider of anatomic, clinical and molecular pathology services, as well as one of the largest providers of women’s health services in the United States. Privately held and physician-centric, PathGroup works seamlessly with customers to provide superior diagnostic services – a vital link in the cycle of patient relationships. PathGroup uses the latest in proprietary and industry standard technology to deliver fast, accurate results. The company provides clients with the highest quality of services available, consistently exceeding the expectations of physicians, employees, payers and most importantly, patients. One Lab; Total Service.. More information about PathGroup can be found at www.pathgroup.com The PathGroup social media sites are produced and maintained as a public forum by PathGroup, Nashville, Tennessee. Links to other Internet sites should not be construed as an endorsement of the views contained therein. We respect our followers'​ rights and it is inappropriate to post any patient related information or requests. Should such posts be published, they will be immediately deleted.

Premier Medical Group is Clarksville's hometown healthcare choice. We have always called Montgomery County home, and we're proud to be part of Clarksville's legacy and growth. Established in 1995, Premier Medical Group is the largest physician-owned and directed, multi-specialty group in the Clarksville-Montgomery County area. With more than 50 board-certified physicians and mid-level providers, we provide a wide range of healthcare services to families and businesses throughout the region. Premier Medical has five medical specialties: Family Medicine, Internal Medicine, OB/GYN, Occupational and Travel Medicine, and Pediatrics. In addition, we offer ancillary services including Clinical Research, Diagnostic Imaging, Medical Laboratory, Virtual Visits, and two Same-Day Clinics that are open seven days a week. We have a modern, centrally located campus with a workforce of 338 active employees, placing us among the area's largest employers. Premier is recognized by the National Committee for Quality Assurance as a Patient-Centered Medical Home for team-based care, quality, and safety. We have received the Better Business Bureau Torch Award for Ethics, annual recognition since 2003 by the Medical Group Management Association, and we hold gold status as deemed by the Montgomery County Green Certification Program for ongoing sustainability initiatives. We are grateful that each patient chooses us for their healthcare needs. Visit PremierMed.com or call 931-245-7000.

Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology company developing immunotherapy medicines based on small molecules called halogenated xanthenes, the entire class.

Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers.

QuantuMDx is dedicated to improving and democratising global health by providing transformative diagnostics to overburdened healthcare systems, empowering frontline healthworkers with intuitive, rapid, accurate and low cost decentralised testing solutions. COVID-19: CE Mark (06/2020)

Rare Disease Therapeutics is a pharmaceutical company that brings orphan drugs to the US market for people with rare diseases and unmet medical needs.

Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings. We recently expanded our aesthetics portfolio to include digital services with the acquisition of an innovative fintech platform. We have assembled a team of motivated, talented professionals who collectively aim to transform patient experiences and disrupt the status quo. Exceptional talents with passion, creativity, and dedication to improving lives will immediately contribute to our ambitious pipeline and unique culture. Our employees work on challenging projects in a supportive environment that provides opportunities for growth and development.

RyMed Technologies, LLC specializes in the development and marketing of innovative safety products for intravenous catheter management. RyMed's products are designed to reduce the two most critical vascular access catheter complications of Catheter-related Bloodstream Infections (CR-BSI) and Intraluminal Thrombotic Catheter Occlusions. RyMed manufactures and distributes the InVision-Plus® needleless connector with Neutral Advantage™ Technology and the InVision-Plus CS--the only needleless connector treated with Chlorhexidine and Silver. RyMed's Neutral Advantage Technology meets a 10-Point Standard; ten features designed to work together to maximize intraluminal catheter protection and prevent catheter-related bloodstream infections (CR-BSIs). RyMed also represents PICC Guard, the only FDA cleared Tamper-Evident and Tamper Resistant technology. PICC Guard can address your opioid epidemic concerns while providing patient centered care.

St. Jude Children's Research Hospital is a healthcare institution specializing in pediatric medical research with a focus on cancer treatment.

Stony Creek Colors manufactures traceable, 100% plant-based indigo dyes that improve soil health and replace harmful, synthetic colorants in global fashion supply chains. Stony Creek is the fastest growing manufacturer of natural indigo globally, serving fashion brands as well as an artisan community of professional dyers. We partner with leading denim mills to bring consistent and scalable natural colors into industrial use. Our customers are the world's leading fashion and personal care brands and their suppliers. Our next generation products will fuel clean color innovation in verticals such as cosmetics, personal care, and food.

Simplifying your journey to closure with our collagen + honey advanced wound care products. #woundcareforall Sweetbio is a commercial-ready, medical device company with novel, honey-incorporated wound care products (FDA cleared May 2019).

Thyme Care is a value-based oncology management platform whose mission is to improve the quality of life for people diagnosed with cancer by providing personalized, clinically coordinated care. Thyme Care pairs human guidance with software and analytics to quickly connect members to the right care and provide ongoing support through targeted, evidence-based interventions. Founded by oncology industry veterans and clinicians, the company's approach prioritizes deep provider relationships and integrates with a health plan's existing infrastructure, coordinating value-driven care that leads to better outcomes, lower costs, and an improved member experience. Backed with venture funding from Andreessen Horowitz (a16z), AlleyCorp, Frist Cressey Ventures, Casdin Capital, and Bessemer, Thyme Care partners with health insurance plans and providers to extend the reach of high-quality cancer care through flexible value-based payment arrangements, including risk-based programs. To learn more about how Thyme Care is unlocking high-value care in oncology, visit www.thymecare.com.

UPM Pharmaceuticals is a Bristol Tennessee based contract development and manufacturing organization (CDMO) serving the pharmaceutical and biotechnology industries. UPM provides high quality pharmaceutical drug development services that include formulation development, cGMP manufacturing and packaging, analytical method development and testing from concept through commercialization. UPM is characterized by its strict sense of quality, timeliness, sound scientific fundamentals, and affordability with which we complete all our projects. We focus on drug development and manufacturing for dosages with oral routes of administration in solid forms such as capsules and tablets, and semi-solid creams and ointments.

Vanderbilt University is a Higher Education institution that offers academic programs and conducts research.

Virtuoso's mission is to transform minimally invasive surgery by providing surgeons with dexterous, accurate, and cost-effective endoscopic robotic tools.

Vision is humanity’s most treasured sense. Yet for countless people worldwide, the scourge of eye infection and disease has stolen this precious faculty of sight, cloaking them in shadows, discomfort, and often perpetual darkness. VisiRose is pioneering a global revolution to protect and restore vision. Through invention, science, and technology, VisiRose is committed to reclaiming what has been lost, offering the transformative gift of renewed sight. VisiRose is a clinical-stage biotechnology company of the University of Miami and Provectus Biopharmaceuticals, focused on commercializing the Miller School of Medicine’s Bascom Palmer Eye Institute and its Ophthalmic Biophysics Center’s innovative ocular research using bioactive synthetic small molecule rose bengal. VisiRose is transforming lives through the restoration of vision.